Maria Jesus
Peñarrubia Ponce
![Foto de Maria Jesus](/img/nophoto.png)
![Foto de Hospital Clínico Universitario Lozano Blesa](/img/noimage_org.png)
Hospital Clínico Universitario Lozano Blesa
Zaragoza, EspañaPublikationen in Zusammenarbeit mit Forschern von Hospital Clínico Universitario Lozano Blesa (6)
2021
-
R-COMP versus R-CHOP as first-line therapy for diffuse large B-cell lymphoma in patients ≥60 years: Results of a randomized phase 2 study from the Spanish GELTAMO group
Cancer Medicine, Vol. 10, Núm. 4, pp. 1314-1326
2020
2016
-
Eltrombopag safety and efficacy for primary chronic immune thrombocytopenia in clinical practice
European Journal of Haematology, Vol. 97, Núm. 3, pp. 297-302
2015
-
Successful discontinuation of eltrombopag after complete remission in patients with primary immune thrombocytopenia
American Journal of Hematology, Vol. 90, Núm. 3, pp. E40-E43
-
Switching to second-generation tyrosine kinase inhibitor improves the response and outcome of frontline imatinib-treated patients with chronic myeloid leukemia with more than 10% of BCR-ABL/ABL ratio at 3 months
Cancer Medicine, Vol. 4, Núm. 7, pp. 995-1002